Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Saving for the Holidays
With the holidays approaching, now's a good time to start budgeting. Cheddar News provides some tips on where and how to save.
Load More